2Serfaty L, Thabut D, Zoulim F, et al. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.Hepatology, 2001, 34:573-577.
3EASL Jury. EASL International Consensus Conference on Hepatitis B. J Hepatol, 2003, 38:533-540.
4Buti, M Esteban R. Entecavir, FTC, L-FMAU, LdT and others. J Hepatol, 2003, 39:S139-S142.
5Schalm SW, Heathcote J, Cianciara J, et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut, 2000, 46:562-568.
6Barbaro G, Zechini F, Pellicelli AM, et al. Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial. J Hepatol, 2001,35:406-4
7Schiff ER, Dienstag JL, Karayalcin S, et al. Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders. J Hepatol, 2003,38:818-826.
8Sanantonio T, Niro GA, Sinisi E, et al. Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B: a controlled pilot study. J Hepatol, 2002,36:799-804.
9Tatulli I, Francavilla R, Rizzo GL, et al. Lamivudinne and alpha-interferon in combination for precore mutant chronic hepatitis B. J Hepatol,2001,35:805-810.
10Patrick Marcellin, George KK Lau, Ferruccio Bonino, et al. A Phase Ⅲ, partially double-blinded study evaluating the efficacy and safety of peginterferon alfa-2a(40 KD)(Pegasys○R ) alone or in combination with lamivudine vs lamivudine in 546 patients wit
5McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection : relation of age to the clinical expression of disease and sub- sequent development of the cartier state. J Infect Dis 1985 ; 151 : 599- 603.
6Lee CH, Kim SO, Byun KS, et al. Predominance of hepatitis B vi- YMDD mutants is prognostic of viral DNA break- through. Gastroenterology 2006 ; 130 : 1144 - 1152.
